04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
New Jersey has expanded its medical marijuana program and—for the first time since the state enacte...
Read More >
The Coronavirus Aid, Relief, and Economic Security (CARES) Act, among other economic stimulus measur...
Read More >
In today’s edition of the Daily Compliance News: 1. How AB InBev uses the ‘ethical edge’. (WSJ) ...
Read More >
Georgia recently issued a final rule which, among other things, amended certain disclosure and emplo...
Read More >
AB Stable VIII LLC v. MAPS Hotels and Resorts One LLC, C.A. No. 2020-0310-JTL (Del. Ch. Nov. 30, 202...
Read More >
The Department of Labor (DOL) issued a final rule last weekend that codifies a majority of the chang...
Read More >